Roaccutane® (isotretinoin)
Pharmaceutical Product Information
Roaccutane® (isotretinoin)
As of April 2025, Roche transferred the sponsorship and management of supply, customer support, medical information, regulatory services, sales and marketing of Roaccutane (isotretinoin) 20 mg tablets in Australia to Pharmaco (Australia) Ltd. The current Consumer Medicine Information (CMI) and Product Information (PI) for Roaccutane are available from the Therapeutic Goods Administration (TGA) website at: https://www.ebs.tga.gov.au/
Solutions